Loading clinical trials...

COMPLETEDNA

Diagnostic Ultrasound for Measuring Fat of the Body

NCT03871556•Northwestern University

Summary

The purpose of this study is to provide information about human subcutaneous fat thickness at different anatomic sites on the body by measuring these thicknesses with a diagnostic ultrasound and also by correlating patient perceptions of body image with measured fat distribution. Subjects currently living in the Chicago metropolitan area and meet inclusion/exclusion criteria will be considered for enrollment.

Eligibility

Age

18 - 85 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Males or females 18-85 years old.
•Subjects are in good health as judged by the investigator.
•Subjects with Body Mass Index (BMI) between 18-29.99.
•Subjects who are willing and have the ability to understand and provide informed consent for participation in the study and are able to communicate with the investigator

Exclusion Criteria

•Evidence of another skin condition affecting the treatment area that would interfere with clinical assessments
•Pregnant or breast feeding
•Uncooperative patients or patients with neurological disorders who are incapable of following directions
•Subjects who are unable to understand the protocol or give informed consent (including non-English speaking patients)

Locations (1)

Northwestern University Department of Dermatology

Chicago, Illinois, United States

Key Dates

Start Date

March 20, 2019

Primary Completion Date

October 2, 2022

Completion Date

October 2, 2022

Last Updated

September 28, 2023

Enrollment

ACTUAL participants

Conditions

Subcutaneous Fat

Interventions

LOGIQ P6 Diagnostic Ultrasound

DIAGNOSTIC_TEST

A Study to Evaluate the Efficacy and Safety of CBL-514 Injection for Reducing Subcutaneous Fat

NCT07140939

Subcutaneous Fat

View study

COMPLETEDPHASE2

Safety and Efficacy Study of 10XB-101 in Adults With Bilateral Flank Adiposity

NCT05760248

Subcutaneous Fat Disorder

View study

COMPLETEDPHASE2

A Study to Evaluate the Efficacy, Safety and Tolerability of CBL-514 Injection for Reducing Abdominal Subcutaneous Fat

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 28, 2023Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Diagnostic Ultrasound for Measuring Fat of the Body

Inclusion Criteria

Exclusion Criteria

A Study to Evaluate the Efficacy and Safety of CBL-514 Injection for Reducing Subcutaneous Fat

Safety and Efficacy Study of 10XB-101 in Adults With Bilateral Flank Adiposity

A Study to Evaluate the Efficacy, Safety and Tolerability of CBL-514 Injection for Reducing Abdominal Subcutaneous Fat

Combination of Light and Ultrasound to Reduce Abdominal Fat

Subject Evaluation of a 1064nm Diode Laser/RF

A Study to Evaluate the Pharmacokinetic Profile of CBL-514 Injection in Healthy Volunteers